Đang chuẩn bị liên kết để tải về tài liệu:
Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Although brucea javanica oil liposomes (BJOLs) have been used clinically to treat ovarian cancer, its clinical efficacy is often limited by systemic side effects due to non-specific distribution. Luteinizing hormone releasing hormone receptor (LHRHR) is overexpressed in most ovarian cancers but negligibly expressed in most of the other visceral organs. |

TÀI LIỆU LIÊN QUAN

Integration of metabolites from meta-analysis with transcriptome reveals enhanced SPHK1 in PDAC with a background of pancreatitis

Enhanced preferential cytotoxicity through surface modification: Synthesis, characterization and comparative in vitro evaluation of TritonX-100 modified and unmodified zinc oxide nanoparticles in human breast cancer cell (MDA-MB-231)

Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon

Study protocol: Multi-parametric magnetic resonance imaging for therapeutic response prediction in rectal cancer

Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer

Enhanced immunity in a mouse model of malignant glioma is mediated by a therapeutic ketogenic diet